Erasca Inc

2
NAS:ERAS (USA)  
$ 1.89 +0.005 (+0.27%) 03:54 PM EST
At Loss
P/B:
0.90
Market Cap:
$ 284.81M
Enterprise V:
$ 28.32M
Volume:
373.48K
Avg Vol (2M):
836.45K
Warning! GuruFocus detected 1 Severe warning sign with ERAS. Try a 7-Day Free Trial to check it out.
Volume:
373.48K
Market Cap $:
284.81M
At Loss
Avg Vol (2M):
836.45K
Enterprise Value $:
28.32M
PB Ratio:
0.90
Alerts Website SEC Filings Stock PDF
Dataset
Financial Download Manual of Stocksâ„¢

Business Description

Erasca Inc
NAICS : 541714 SIC : 2834
ISIN : US29479A1088
https://www.erasca.com
3115 Merryfield Row, Suite 300, San Diego, CA, USA, 92121
Compare
Compare
AURACHRSSPRYURGNOCSITOSLXRXMGNXORICALXOOCSE:NOVO BVRTXREGNASX:CSLSGENXKRX:207940MRNAXBRU:ARGXHKSE:02269BNTX
Traded in other countries / regions
ERAS.USA
IPO Date
2021-07-16
Description
Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's pipeline includes; Naporafenib, a pan-RAF inhibitor with first-in-class potential in NRASm melanoma, RAS Q61X tissue agnostic solid tumors, and other RAS/MAPK pathway-driven tumors, and ERAS-007 (oral ERK1/2 inhibitor) and ERAS-601 (oral SHP2 inhibitor), which target downstream and upstream nodes, respectively, of the RAS/MAPK pathway.

Financial Strength

7/10
Name Current Vs Industry Vs History
Cash-To-Debt 5.59
Equity-to-Asset 0.8
Debt-to-Equity 0.18
Debt-to-EBITDA -0.41
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EBITDA Growth Rate 17.2
3-Year EPS without NRI Growth Rate 14
3-Year FCF Growth Rate 36

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 41.4
9-Day RSI 39.89
14-Day RSI 41.79
6-1 Month Momentum % -7.73
12-1 Month Momentum % -20.37

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 12.26
Quick Ratio 12.26
Cash Ratio 11.94

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -87.7
Shareholder Yield % -5.41

Profitability Rank

1/10
Name Current Vs Industry Vs History
ROE % -34.42
ROA % -27.94
ROIC % -139.87
ROC (Joel Greenblatt) % -224.88
ROCE % -33.9

GF Value Rank

Name Current Vs Industry Vs History
PB Ratio 0.9
Price-to-Tangible-Book 0.9
EV-to-EBIT -0.19
EV-to-Forward-EBIT -0.2
EV-to-EBITDA -0.2
EV-to-FCF -0.23
Price-to-Net-Current-Asset-Value 1.18
Price-to-Net-Cash 1.22
Earnings Yield (Greenblatt) % -526.32
FCF Yield % -43.18

Financials (Next Earnings Date:2024-05-15 Est.)

ERAS's 30-Y Financials
AAPL
Income Statement Breakdown
No Enough Data
AAPL
Balance Sheet Breakdown
No Enough Data
AAPL
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:ERAS

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Erasca Inc Executives

Details

GF Value

ERAS

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -0.82
Beta 0
Volatility % 71.93
14-Day RSI 41.79
14-Day ATR ($) 0.147437
20-Day SMA ($) 2.046
12-1 Month Momentum % -20.37
52-Week Range ($) 1.51 - 3.375
Shares Outstanding (Mil) 151.49

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Erasca Inc Filings

Filing Date Document Date Form
No Filing Data

Erasca Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Erasca Inc Frequently Asked Questions

What is Erasca Inc(ERAS)'s stock price today?
The current price of ERAS is $1.89. The 52 week high of ERAS is $3.38 and 52 week low is $1.51.
When is next earnings date of Erasca Inc(ERAS)?
The next earnings date of Erasca Inc(ERAS) is 2024-05-15 Est..
Does Erasca Inc(ERAS) pay dividends? If so, how much?
Erasca Inc(ERAS) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1
Research Tools
All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board
Product
Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文
Education
Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation
Company
About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program
Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey
Follow Us
download GuruFocus on Apple store download GuruFocus on Google Play
Disclaimers
GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.
© 2004-2024 GuruFocus.com, LLC. All Rights Reserved.